超出血管内皮生长因子-A抑制的新目标:通过治疗新血管与年龄相关的黄斑退化改善视力
Arshad M Khanani1,2, Sophie J Bakri3, Carl Regillo4
1Sierra Eye Associates, Reno, NV, USA. arshad.khanani@gmail.com.
Eye (London, England)
|October 11, 2025
概括
针对只有VEGF-A的神经血管年龄相关黄斑变性 (nAMD) 治疗结果各不相同. 抑制VEGF-C和VEGF-D的新疗法,如sozinibercept,为nAMD患者提供了改善的视力收益.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 药物开发 药物开发
背景情况:
- 神经血管与年龄相关的黄斑变性 (nAMD) 管理旨在改善视力敏度.
- 目前的标准治疗方法,主要是血管内皮生长因子 (VEGF) -A抑制剂,在一些患者中产生低于最佳的结果.
- 包括VEGF-C和VEGF-D在内的VEGF家族在nAMD的发病过程中发挥着作用,这可能解释了治疗的变异性.
研究的目的:
- 审查VEGF家族在nAMD中的作用.
- 探索针对nAMD的VEGF-A以外的媒介的新疗法.
- 评估sozinibercept在nAMD的联合治疗中的疗效.
主要方法:
- 在nAMD中对VEGF家族配体和受体的文献综述.
- 对新型nAMD疗法的临床试验数据的分析.
- 组合治疗 (索齐尼伯塞普特+拉尼比祖马布) 与标准治疗 (单独拉尼比祖马布) 的比较.
主要成果:
- 作为VEGF-C和VEGF-D的抑制剂Sozinibercept在nAMD中显示出有前途的疗效.
- 与索兹尼伯塞普特和拉尼比祖马布的联合治疗与拉尼比祖马布单一治疗相比,显示出更好的视力增长.
- 这些发现支持针对更广泛的VEGF家族的多方面的方法.
结论:
- 目前的VEGF-A抑制剂对于所有nAMD患者来说都不足.
- 针对VEGF-C和VEGF-D提供了一个有前途的战略,以改善nAMD治疗.
- 像sozinibercept这样的研究疗法可能会增强nAMD的视觉结果.
更多相关视频
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.4K
06:48Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
22.1K
相关概念视频
01:27Open Angle Glaucoma: Treatment
961
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
961
01:28Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
01:25Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K